Companies /Healthcare

Atossa Genetics Inc

NASDAQ: ATOS Biotechnology
$2.05
▼ $0.13 (−5.96%) today
Markets closed · 1:31am ET

Fundamentals

Market Cap
$20.5M
EPS (TTM)
$-4.12
52-Week Range
$2 – $19
Street Target
$18.67

About Atossa Therapeutics

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.

ATOS Coverage